EFL苏州永沁泉

*author：*Lyncy · *date：*2024-8-13 11:57

Company Profile

EFL is a comprehensive service provider for the entire process of regenerative medicine research and transformation. EFL was founded in 2017, based on the research achievements of the biomanufacturing laboratory led by Professor He Yong from Zhejiang University, for industrial transformation. We are the leading manufacturer of biomedical hydrogels and 3D bioprinter in China.

The EFL academic team was invited to publish two monographs on 3D bioprinting, with over 50 authorized invention patents; The EFL academic team has published 105 SCI indexed papers, including Science Translational Medicine, Nature Communications, and Science Advances (40% of papers have an impact factor greater than 10, and 13 papers have been selected as covers)；

EFL brand company undertakes 8 scientific and technological projects, including national key research and development and Jiangsu provincial key research and development.

In 2023, we will be recognized as a "Jiangsu Province Specialized, Refined, Unique and New Small and Medium sized Enterprise" and a "China Invisible Unicorn Enterprise"

In 2020, we were recognized as a "National High tech Enterprise", "Technology based Small and Medium sized Enterprise", and "Jiangsu Province Private Technology Enterprise"

EFL Products and Services

EFL provides comprehensive services around regenerative medicine, including "science popularization → service research → assistance in transformation".

EFL provides biomedical hydrogels, processing and control equipment, monitoring and analysis instruments and other overall solutions for researchers seeking reliable and efficient regenerative medicine by building two major technology platforms, namely, biomaterials and biological manufacturing, to efficiently empower the whole process from regenerative medicine research to transformation.

1.Science popularization of regenerative medicine

EFL popular science platform strengthens high-quality content output and provides a daily learning and communication platform for regenerative medicine researchers

EFL collaborates with frontline researchers to create a self driving academic community where all industry professionals work together to create content

2.Solutions for biomaterials

Fundamental Research：Basic research: AFM issued a document to analyze the crosslinking theory of UV curable hydrogels, and AHM issued a document to establish the standardization and performance manual of UV curable hydrogels

Quantity Product Control：The synthesis process was redesigned to solve the mass production problem of GelMA hydrogel, and more than ten quality control indicators were established to ensure stable quality. Lead the drafting of the first industry standard related to UV curable GelMA gel (approved)

Promotion and Sales：There are more than 50 kinds of UV curable hydrogels, which occupy the first place in the domestic scientific research market and are exported to dozens of countries such as Europe and the United States.